FSGEX
Price
$20.81
Change
+$0.01 (+0.05%)
Updated
Jul 31 closing price
Net Assets
74.78B
GSIFX
Price
$34.39
Change
-$0.19 (-0.55%)
Updated
Jul 31 closing price
Net Assets
848.38M
Interact to see
Advertisement

FSGEX vs GSIFX

FSGEX vs GSIFX Comparison Chart in %
View a ticker or compare two or three
VS
FSGEX vs. GSIFX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSGEX is a Hold and GSIFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSGEX has more cash in the bank: 74.8B vs. GSIFX (848M). FSGEX pays higher dividends than GSIFX: FSGEX (2.66) vs GSIFX (1.80). FSGEX was incepted earlier than GSIFX: FSGEX (17 years) vs GSIFX (34 years). GSIFX (1.32) is less costly to investors than FSGEX (0.01). GSIFX is a more actively managed with annual turnover of: 40.00 vs. FSGEX (8.00). FSGEX has a lower initial minimum investment than GSIFX: FSGEX (0) vs GSIFX (1000). FSGEX annual gain was more profitable for investors over the last year : 28.80 vs. GSIFX (15.96). FSGEX return over 5 years is better than : 55.46 vs. GSIFX (27.69).
FSGEXGSIFXFSGEX / GSIFX
Total Expense Ratio0.011.161%
Annual Report Gross Expense Ratio0.011.321%
Fund Existence17 years34 years-
Gain YTD13.7167.234190%
Front LoadN/A6%-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets74.8B848M8,821%
Annual Yield % from dividends2.661.80148%
Returns for 1 year28.8015.96180%
Returns for 3 years63.2237.30169%
Returns for 5 years55.4627.69200%
Returns for 10 years135.05138.7997%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FCUCX20.370.29
+1.44%
NYLI PineStone U.S. Equity Class C
MAILX24.190.17
+0.71%
BlackRock International Instl
MMMMX56.82-0.14
-0.25%
Victory Integrity Discovery Member
PDGIX89.88-0.39
-0.43%
T. Rowe Price Dividend Growth I
MGHRX63.84-1.31
-2.01%
Morgan Stanley Inst Growth IR